Blackford

by Blackford Analysis Ltd.  · Based in United Kingdom → — Your Enterprise AI Partner for Medical Imaging
Interventional Radiology Nuclear Medicine Radiology
Website
Claim this tool
Is this the maker? Claim the company →

Contact for pricing
Regulatory Status Disclosed

Overview

Blackford Analysis provides a dedicated platform and service for the effective selection, deployment, orchestration, and use of best-in-class medical imaging applications and AI. The Blackford Platform is designed to integrate seamlessly with existing systems, simplifying the management of multiple AI applications and algorithms, and reducing the load on imaging platforms. The company operates as a strategic AI partner, offering access to a tried-and-tested core platform, tailored services, and a portfolio of over 140 applications to help healthcare providers drive efficiencies, advance diagnostic confidence, and improve patient outcomes.

Blackford’s journey began in 2010 by developing a product to improve the diagnostic process for MRI and CT scans, allowing radiologists to quickly assess and compare changes between scans. This product is now utilized in over 1,000 hospitals and imaging centers, primarily in the US, Australia, and New Zealand. In 2015, Blackford transitioned to a platform business model, delivering third-party products to both existing and new customers.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Interoperability Engine (DICOM compliant + HL7)
  • Configurable Dataflow
  • AI Portfolio Access (140+ applications)
  • AI Analytics, Quality + Safety
  • Precision AI Orchestration
  • Data Privacy + Security
  • Flexible AI Deployment (on-premise, cloud, hybrid)
  • 24/7 Performance Monitoring via Blackford Dashboardu2122
  • Zero-Footprint Accept/Reject Tool
  • Customer Developed AI Support

Use Cases

  • Streamlining AI adoption across healthcare enterprise
  • Enhancing diagnostic confidence and patient outcomes
  • Automating radiology workflows
  • Efficient evaluation and deployment of AI applications
  • Reducing missed diagnoses and realizing reimbursement opportunities
  • Real-time collaboration among multi-disciplinary medical experts

What Physicians Need to Know

Evidence Base
Blackford provides a platform that offers a curated marketplace of over 140 regulatory-approved medical image analysis applications and AI algorithms from over 50 partner vendors. These applications cover various subspecialties like Neurology, Thoracic, Cardiology, MSK, Body, Breast, and Pediatric, and support modalities such as MRI, US, PET, CT, X-ray, and MAM. The platform ensures that applications are vetted and tested to meet strict criteria, including FDA clearance and clinical and interoperability testing. Blackford also supports the deployment of hospital-built AI algorithms for research.
Clinical Validation Studies
Blackford's 'MEASURE' service helps healthcare providers evaluate AI solutions by orchestrating side-by-side evaluations of specific applications in the customer's environment, using their own data. This evidence-based approach aims to determine if an AI application delivers on its claimed accuracy and efficiency gains for identified clinical and business problems. They also offer the Aival Analysis Lab, a software suite that allows clinical users to independently evaluate, compare, and monitor the performance of AI products on the market.
Alert Fatigue Management
While Blackford's platform integrates numerous AI applications, it focuses on seamless workflow integration and delivering relevant, condition-specific information to improve diagnostic confidence and reduce manual input. The platform aims to automate workflows and standardize results, pre-processing images and delivering outcomes back to PACS or other image viewers, which can help mitigate alert fatigue by providing pre-screened images and identified features within the existing workflow. The Blackford Dashboard monitors platform health and activity, which can help IT teams identify and address issues like data transmission errors early on, preventing disruptions that could lead to alert overload.
Override Rate Data
Specific override rate data for Blackford's integrated AI applications is not explicitly detailed. However, the platform's 'zero-footprint Accept/Reject Tool' allows for the review of AI results before they are sent to PACS, implying a mechanism for clinician oversight and potential 'overrides' or adjustments of AI findings.
Drug Interaction Checking
Blackford's primary focus is on medical imaging analysis and AI orchestration. There is no explicit mention of drug interaction checking capabilities within their platform or integrated applications. Drug interaction checking is typically a function of pharmacy information systems or dedicated clinical decision support tools focused on medication management.
Differential Diagnosis Support
Blackford's platform provides access to a wide range of AI applications that aid in diagnosis by detecting numerous findings in medical images. For example, some integrated applications can detect up to 130 findings in CT brain scans and up to 124 chest X-ray findings, supporting more accurate diagnosis and efficiency improvements. This capability can contribute to differential diagnosis by providing comprehensive information and insights derived from medical images.
Guideline Update Frequency
Blackford partners with a wide range of AI technology providers, ensuring access to multiple FDA-cleared imaging applications and AI algorithms. The platform's cloud-based technology allows for syncing new software updates as they are released, providing users with the latest reports and application versions. Blackford's team also continually reviews the medical AI space to ensure customers have access to a comprehensive and up-to-date portfolio of AI applications.
Clinical Workflow Integration
The Blackford Platform is purpose-built for seamless integration into existing clinical systems, including PACS and other image viewers. It automates workflows by pre-processing images, extracting relevant information, and delivering standardized results and reports directly into the radiologist's standard reading workflow. The platform is DICOM compliant and integrates with DICOM modality worklist to pre-fetch prior studies, and uses HL7 for orchestration and reporting. This integration aims to increase efficiency, reduce errors, and minimize manual input, allowing clinicians to remain in their standard workflow.
Decision Audit Trail
Blackford Dashboardu2122 provides 24/7 insight into the platform's health and all activity and data being processed. The customizable AI Analytics Suite offers rich and flexible access to comprehensive clinical data and metrics, supporting continuous and periodic monitoring of AI application performance. This focus on monitoring and analytics suggests the capability to track the impact, safety, and quality of AI, which would inherently involve a form of audit trail for decisions influenced by the platform's insights.
Physician Tip

Leverage Blackford's curated marketplace to access a broad spectrum of regulatory-approved AI applications directly within your existing PACS workflow, minimizing disruption and training. Utilize the platform's automated pre-processing and standardized reporting to enhance diagnostic confidence and efficiency. Actively engage with the 'Accept/Reject Tool' to maintain clinical oversight of AI-generated findings. Explore the AI Analytics Suite to understand the performance and impact of AI tools on your practice and patient outcomes.

Blackford Platform is designed for seamless integration with existing imaging informatics systems, including PACS, and is DICOM and HL7 compliant. It partners with major imaging system providers like GE Healthcare, Intelerad Medical Systems, IBM, and Philips. The platform supports the deployment of both commercial and in-house developed AI applications, offering flexible deployment options (on-premise, cloud, or hybrid).

Details

Category Clinical Decision Support & Reference, Radiology & Imaging AI
Pricing Contact for pricing
DeploymentOn-premise, cloud, or hybrid model
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

Blackford's AI portfolio includes applications with FDA clearance. The platform facilitates the use of regulatory-approved medical image analysis applications and AI algorithms.
Integrations
EHR Not specified
Specialties Interventional Radiology, Nuclear Medicine, Radiology

What the Web Says

Blackford Analysis is a company that provides an AI platform and a portfolio of over 125 medical imaging AI applications to healthcare providers. The platform aims to streamline AI adoption, improve diagnostic confidence, enhance efficiency, and ultimately improve patient outcomes. Blackford's solutions are designed to integrate seamlessly into existing workflows and systems, offering a single point of access for managing various AI algorithms and applications.

Overall: Positive

Strengths

  • Seamless integration with existing workflows and PACS systems, requiring no additional training for radiologists.
  • Offers a wide portfolio of 125+ FDA-cleared AI applications from various vendors through a single platform.
  • Helps save clinician time and increases productivity by accelerating the comparison of medical images and automating workflows.
  • Provides expert technical consultation and support for integrating and deploying both commercial and in-house AI applications.
  • Enhances diagnostic confidence and patient outcomes by providing actionable information and supporting clinical decision-making.
  • Reduces deployment time, costs, and long-term maintenance by offering a single vendor and platform for managing multiple AI solutions.

Limitations

  • One opinion suggests that a platform with many applications might not provide the necessary clinical and technological guidance for radiologists to implement AI effectively.
  • Bayer, a pharmaceutical giant, deprioritized its investment in Blackford Analysis as part of a move away from the platform business model.
  • Some general concerns about AI platforms in radiology, as noted in a Reddit discussion, include the importance of assessing model performance, integration into workflow, and the roadmap of upcoming models.
  • A Reddit user mentioned that there aren't any 'great' radiology AI platforms out at the moment.

Based on reviews from: Blackford Analysis - Your Enterprise AI Partner, Blackford Analysis - StudioNorth, Working At Blackford Analysis: Company Overview and Culture - Zippia, Working at Blackford Analysis, Blackford Analysis | For staff - Edinburgh Innovation, Healthcare IT Solutions for Radiology Informatics - Blackford Analysis, Blackford in 2025 - Reviews, Features, Pricing, Comparison - Decide Advisory Services: B2B Reviews, Buying Guides & Best Practices, Blackford Analysis | Edinburgh - Facebook, Platform Strategy: The Physician Perspective - Blackford Analysis, About Us - Blackford Analysis, Expert Technical Consultation for Medical Research Groups - Blackford Analysis, Bayer Steps Back from Blackford - Bold Brain Capital, Navigate Your Way to the Best AI Solutions for Healthcare - Blackford Analysis, Blackford Analysis, the Medical Imaging AI Platform Provider, and Rad AI, the Fastest Growing Radiologist Led AI Company, Announce Strategic Sales Partnership, Anyone here using a radiology AI platform? How did you decide which one was best? - Reddit, Streamline Your Healthcare Administration with Blackford

Last updated: 2026-09-11

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Blackford

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

The Imaging Wire
Bayer Steps Back from Blackford, WCLC 2025, and the Berlin Lawsuit - The Imaging Wire
Bayer announced its decision to deprioritize investment in AI platform company Blackford Analysis and wind down its Calantic Digital Solutions, indicating a shift away from the platform business. This move comes after Bayer acquired Blackford in 2023 and operated it alongside Calantic.
2025-09
AuntMinnie
Bayer pivots away from AI platform business | AuntMinnie
Bayer is discontinuing its Calantic Digital Solutions AI platform and winding down services from its Blackford Analysis subsidiary, marking an end to its five-year initiative in the radiology AI software platform sector. Blackford had provided the infrastructure for Calantic and continued to operate as an independent subsidiary after its acquisition by Bayer in 2023.
2025-09
Signify Research
Bayer's Exits, Three Acquisitions and Reimbursement Realities | Signify Research
Bayer is exiting the radiology AI platform market by discontinuing its Calantic Digital Solutions AI platform and winding down services from Blackford Analysis, which had hosted over 150 third-party applications. This decision was based on a review of market insights and customer needs, with resources being redirected to other growth areas.
2025-10
Signify Research
SPI Medical Imaging: Bayer Backs Out of AI Platforms, Blackford Hangs in the Balance
Bayer has confirmed it will shut down its Calantic AI platform and seek a buyer for Blackford Analysis, ending a significant pharma-backed push into imaging AI and raising questions about the future of AI marketplaces. This de-investment highlights wider uncertainty regarding the commercial viability of imaging AI platforms.
2025-09
Blackford Analysis
Why Enterprise AI is the Future of Healthcare - Blackford Analysis
This article argues for an enterprise-wide AI strategy in healthcare to overcome the limitations of siloed AI applications, emphasizing scalability, unified performance oversight, and streamlined workflows. Blackford, with over 15 years of experience, offers an Enterprise AI platform with over 150 AI applications from 61 vendor partners.
2025-08
Edinburgh Innovation
Blackford Analysis | For staff - Edinburgh Innovation
Blackford Analysis, a University of Edinburgh spinout, provides a platform for accessing and managing regulatory-approved medical image analysis applications and AI algorithms. After its acquisition by Bayer in 2023, Blackford continues to operate independently, expanding its presence globally.
2025-06
GE HealthCare
GE HealthCare accelerates artificial intelligence adoption with new offering to advance enterprise imaging
GE HealthCare is integrating Blackford's AI-enabled application orchestration feature into its True PACS and Centricity PACS to help radiologists manage increasing workloads and complex exams. This collaboration aims to provide an AI-enabled platform with a catalog of third-party AI applications across various clinical areas.
2024-10
Blackford Analysis
How do you know if your AI is performing as expected? - Blackford Analysis
This article discusses the importance of post-market monitoring for medical imaging AI, highlighting that regulatory clearance is a snapshot of performance and real-world performance can differ. It notes that the regulatory environment, particularly the EU AI Act, is catching up with specific requirements for bias testing and transparency.
2026-08

Videos

Product demos, reviews, and walkthroughs for Blackford.

View all on YouTube

Frequently Asked Questions

Blackford's Enterprise AI Platform is designed for seamless integration with existing workflows, including PACS and other imaging informatics systems. It provides an interoperability engine that delivers AI results in the right format for your systems at the right time, allowing radiologists to remain in their standard workflow without additional training or integration.
Blackford is committed to high standards of information security and privacy, adhering to HIPAA and GDPR. They are HITRUST, NIST CSF, and ISO 27001 certified, implementing robust risk management, strict access controls, encryption, and regular audits. The platform can be deployed on-premise, keeping patient data within the healthcare institution, and a zero-footprint Accept/Reject Tool allows clinicians to validate AI results before they are sent to PACS.
While there are various clinical decision support tools available, including reference-based systems like UpToDate and integrated CDS workflows like Glass Health, Blackford differentiates itself as an enterprise AI orchestration and deployment platform specifically for medical imaging. It offers a single platform to manage and deploy a portfolio of over 140 AI applications from various vendors, simplifying procurement, implementation, and ongoing monitoring.
Specific pricing details for Blackford's platform are not publicly available, as it is an enterprise solution. However, their model aims to reduce procurement and implementation time and costs, as well as long-term maintenance, by providing a single platform for multiple AI applications. Costs would likely be influenced by the scale of deployment, the number of AI applications utilized, and the specific services required.
General challenges with clinical decision support systems can include usability issues and fitting the support into existing clinician workflows. While Blackford aims to mitigate these by integrating seamlessly and providing results within the native PACS viewer, the effectiveness can depend on the specific AI applications deployed and how well they align with a physician's 'mindflow'.
Yes, Blackford's platform is designed to support not only applications from their comprehensive portfolio of over 140 AI solutions but also allows for the quick and efficient deployment of in-house developed AI applications. This flexibility enables healthcare providers to integrate their own AI initiatives.
Physicians can expect Blackford to elevate diagnostic confidence, enhance patient outcomes, and automate workflows by providing actionable insights and streamlining analysis. The platform aims to reduce planning time and costs, improve reporting for diseases with more quantification, and ultimately help healthcare providers make more informed decisions.

Compare Blackford

VS
Brainomix 360 e-CTA vs Blackford
Clinical Decision Support & Reference Adjacent · 60/100
Brainomix 360 e-CTA is a specialized AI tool for acute stroke assessment, focusing on collateral assessment and large vessel occlusion detection on CT angiography scans. Blackford, on the…
VS
BriefCase vs Blackford
Clinical Decision Support & Reference Adjacent · 65/100
Aidoc's BriefCase is an AI-powered communication and collaboration solution that streamlines the sharing of critical medical imaging findings, focusing on specific AI algorithms for triage and notification. Blackford,…

Related Tools

Cortex
Cortex
Clinical Decision Support & Reference
Cortex Workspace is a secure, HIPAA-compliant AI platform designed to streamline healthcare workflows and enhance decision-making for physicians.
Starts free, then $29/month for individual plan (save 10% annually). other plans: enthusiast ($99/month), business ($349/month), enterprise (contact sales).
SureMediks ProView
SureMediks (Rasimo Systems, LLC)
Clinical Decision Support & Reference
SureMediks is an AI-powered clinical decision support and metabolic health platform that automates care workflows for specialists, providing AI-generated patient summaries, automated chart review, and real-time biometric alerts.
SOAP Health
SOAP Health
Clinical Decision Support & Reference
SOAP Health is a Florida-based startup transforming patient intake with AI-powered diagnosis, offering a comprehensive solution that improves diagnosis accuracy and empowers patients and physicians.
Oxipit ChestLink
Oxipit (part of Sectra group)
Clinical Decision Support & Reference
Oxipit ChestLink is the world's first CE Class IIb-certified autonomous AI application for healthy chest X-ray reporting, capable of identifying normal studies with 99.9% sensitivity. It automates the reporting of normal chest X-rays, reducing radiologist workload and improving efficiency.
KATE AI
Mednition
Clinical Decision Support & Reference
KATE AI is a nurse-built clinical decision support tool for emergency departments that analyzes incoming patients in real-time to flag high-risk cases that standard acuity scoring might miss. It has supported over 5,000,000 patient visits, helping emergency teams deliver safer, faster, and more informed care.
Fee-based, not publicly disclosed.
MCG Health
MCG Health
Clinical Decision Support & Reference
MCG Health provides industry-leading evidence-based guidance and technologies to optimize health outcomes, drive operational efficiency, and achieve cost savings. Their solutions are utilized by thousands of hospitals, a majority of U.S. health plans, and various government health programs.
Contact for pricing

See all Clinical Decision Support & Reference tools →

Suggest an Edit → | Last Verified: 2026-06-11 | First Added: 2026-06-11
AI Tool Finder
AI-powered search. Results may not be comprehensive.